One IPO and four SPACS debuted this week. Six IPOs and three SPACs submitted initial filings. Malaysian aquaculture company Megan Holdings (MGN) priced its US IPO at the low end of its range, to raise $5 million at a $65 million market cap. The company...read more
Drugs Made In America Acquisition II, a blank check company targeting the pharmaceutical industry, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one right to receive one-tenth of a share upon the...read more
Seven IPOs debuted this week, while one small IPO and five SPACs submitted initial filings. Consumer intelligence provider NIQ Global Intelligence (NIQ) priced its IPO below the midpoint to raise $1.1 billion at a $6.2 billion market cap. The company is a...read more
Drugs Made In America Acquisition II, a blank check company targeting the pharmaceutical industry, filed on Monday with the SEC to raise up to $500 million in an initial public offering. The company plans to raise $500 million by offering 50 million units at...read more
US IPO Weekly Recap: One small debut as more names join the pipeline
One IPO and four SPACS debuted this week. Six IPOs and three SPACs submitted initial filings. Malaysian aquaculture company Megan Holdings (MGN) priced its US IPO at the low end of its range, to raise $5 million at a $65 million market cap. The company...read more
SPAC Drugs Made In America Acquisition II raises $500 million in the biggest blank check IPO since 2022
Drugs Made In America Acquisition II, a blank check company targeting the pharmaceutical industry, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one right to receive one-tenth of a share upon the...read more
US IPO Weekly Recap: NIQ flops and Accelerant shines in 7 IPO week
Seven IPOs debuted this week, while one small IPO and five SPACs submitted initial filings. Consumer intelligence provider NIQ Global Intelligence (NIQ) priced its IPO below the midpoint to raise $1.1 billion at a $6.2 billion market cap. The company is a...read more
SPAC Drugs Made In America Acquisition II files for a $500 million IPO, targeting pharmaceuticals
Drugs Made In America Acquisition II, a blank check company targeting the pharmaceutical industry, filed on Monday with the SEC to raise up to $500 million in an initial public offering. The company plans to raise $500 million by offering 50 million units at...read more